C
CardioMEMS
Wireless sensing and communication technology solutions for severe chronic cardiovascular diseases in the human body
About CardioMEMS
Abbott's cardiovascular division specializes in developing advanced medical devices and technologies aimed at improving patient care in the cardiovascular field. The company serves healthcare professionals and institutions by providing a wide range of products, including stents, heart valves, and remote monitoring systems for chronic heart failure patients. Operating in the global healthcare market, Abbott leverages its extensive research and development capabilities to innovate and bring effective solutions to market. The business model revolves around the sale of these medical devices and associated services, generating revenue through direct sales to hospitals and healthcare providers, as well as through ongoing support and maintenance contracts. Abbott's cardiovascular products are designed to meet the needs of physicians and patients, ensuring better health outcomes and streamlined medical procedures.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2001
- Headquarters
- Atlanta, United States
- Employees
- 39
- Open positions
- None listed
- Dealroom signal
- 76.5/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Cardiology and cardiovascular, Non-Invasive medical devices and treatments, Spinout, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing, SaaS
- Client focus
- b2b
- Investment activity
- 2 companies, latest Jun 2013
- Capital deployed
- $60M
- Preferred round
- SERIES E
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | May 2014 | $455M | $455M | St. Jude Medical | — |
| GROWTH EQUITY VCOther financing | Sep 2010 | $60M | — | St. Jude Medical | — |
Growth signals
Latest recorded traffic for CardioMEMS is 180K monthly website visits, up 0% over the last three months. CardioMEMS's team declined 15.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Spinal ModulationMenlo Park, United StatesMedical device company developing spinal cord neurostimulator systems for the treatment of chronic intractable pain
$180Mvaluation
Micell TechnologiesDurham, United StatesBiomedical device company developing interventional cardiology systems for vascular drug delivery
$247Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
- BPBoston Millennia Partners
Arboretum Ventures
Johnson & Johnson Development Corporation
Guidant Corporation- FPFoundation Medical Partners
Series B and later8 investors entered at this stage
Easton Capital Investment Group- AHArcapita Group Holdings
Medtronic
Johnson & Johnson- VCVision Capital
Rockport Venture Partners- APAperture Venture Partners
St. Jude Medical
Other known investors1 additional known investor
Georgia Institute of Technology
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about CardioMEMS on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CardioMEMS’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.